FMBA begins trials of its coronavirus vaccine

Science, technology and technology news

FMBA begins trials of its coronavirus vaccine

FMBA begins trials of its coronavirus vaccine

On July 19, the Federal Biomedical Agency began clinical trials of its anticoid vaccine, according to the FMBA website.

The department has received the appropriate permission from the Russian Ministry of Health.

200 people from 18 to 60 years old will take part in the research.

As a reminder, the FMBA scientific center received a patent for the drug “Mir-19” on April 11. Its name stands for small interfering RNA. The drug is expected to inhibit the replication of the virus and prevent the most severe forms of COVID-19.

Last week it was reported that the drug will be relevant for the British and Indian strains of the coronavirus.

The new smartphone Redmi 9 Activ is priced less than 10,000 rubles

The Chinese brand Redmi has officially unveiled the new budget smartphone Redmi 9 Activ. The basic version of the novelty Read more

Durov explained the blocking of the Smart Voting bot by the interests of millions of users

Telegram blocked the Smart Voting bot during the elections to the State Duma due to the fact that otherwise the Read more

Leave a Reply